Skip to main content
OpenTrials
Completed

NCT Number: NCT02972775

15-year Mortality After Hospitalization for Exacerbation of Chronic Obstructive Pulmonary Disease

The investigators examine the 15-year mortality after an admission for an exacerbation of Chronic Obstructive Pulmonary disease (COPD).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Obstructive Pulmonary Disease Chronic Disease Disease Attributes Exacerbation Copd Lung Diseases Lung Diseases, Obstructive Mortality Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Zuyderland Medical Center

Heerlen, Limburg, 6419 PC, Netherlands

About this study

Several prognostic factors will be examined. Cause of death will be examined. Data will be recruited from medical records and calling general practitioners to find out if a patient is still alive. Statistical analysis will be done with Kaplan Meier, Cox proportional hazards and Chi square

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • admission with exacerbation of COPD

Exclusion criteria

  • none

Treatment and study plan

no interventions. observational study

Other

Primary outcomes

  1. Percentage of patients that died after 15 years

    Time frame: 15 years

    Mortality after 15 years

Secondary outcomes

  1. Prognostic factors for mortality

    Time frame: 15 years

    Age (years), Gender (M / F), Previous hospitalization in the past year (yes/no), Re-admission in the next 5 years (number of readmissions per year), forced expiratory volume in 1 second (in liter), Hypercapnia (carbon dioxide in arterial blood in stable condition above 5.9 kiloPascal (kPa) or not), TLCO (transfusion capacity of the lung for carbon monoxide in percentage of predicted, ml / min / kPa), Comorbidity (Charlson Comorbidity Index) Date and cause of death

  2. Cause of death

    Time frame: 15 years

    Chronic obstructive pulmonary disease, lung carcinoma, cardiovascular, other

Sponsors and collaborators

Lead sponsor

Zuyderland Medisch Centrum

Other

Registry information

Acronym: MORTCOP

Important dates

Study start
2005
Primary completion
2017
Study completion
2017
First posted
Nov 23, 2016
Registry last updated
Jun 4, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.